Advertisement

Breast Cancer Research and Treatment

, Volume 68, Issue 3, pp 199–210 | Cite as

Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose

  • Pehr A.R.M Lind
  • Berit Wennberg
  • Giovanna Gagliardi
  • Tommy Fornander
Article

Abstract

Purpose. This study investigates the incidence of short-term pulmonary complications following radiotherapy (RT) for breast cancer (BC) with different treatment techniques/incidentally irradiated lung volumes and the importance of confounding factors on RT-induced pulmonary complications.

Patients and methods. Prospectively, 475 patients with BC were followed for pulmonary complications 1, 4 and 7 months post-RT. Mean lung dose volume histograms (MDVH) were constructed and compared for the different RT-techniques. Among a subset of the mastectomized patients treated with loco-regional (LR-) RT, who had undergone complete three-dimensional (3-D) dose planning (n= 43), MDVH for asymptomatic patients was compared with MDVH for patients experiencing both radiological and clinical pulmonary side-effects.

Results. Moderate pulmonary complications, that is requiring treatment with corticosteroids, were rare following local RT ( < 1%), but were diagnosed among 11% of the patients treated with LR-RT. A correlation between increasing irradiated lung volumes at the > 20 Gy-level (V20), based on MDVH for the RT-techniques, and pulmonary complications was found (P < 0.001). Furthermore, increasing age and reduced pre-RT functional level were independently associated with a higher rate of pulmonary complications (P = 0.005 and P = 0.018). Among the subgroup of mastectomized patients treated with LR-RT, who had undergone complete 3-D dose planning, a difference in mean V20 was found between patients experiencing both clinical and radiological pulmonary side-effects compared to patients experiencing neither of the two side-effects (P = 0.007).

Conclusion. Moderate pulmonary complications following local RT for BC are rare. The incidence of short-term moderate pulmonary complications in LR-RT is, however, clinically significant and to define quality assurance guidelines for these RT-techniques, 3-D RT planning can be used.

breast cancer 3 dimensional dose planning pulmonary side-effects radiotherapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lind PARM, Gagliardi G, Wennberg B, Fornander T: A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol 36: 509-515, 1997Google Scholar
  2. 2.
    Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR: Radiation pneumonitis in breast cancer treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 21: 355-360, 1991Google Scholar
  3. 3.
    Bartelink H, Garavaglia G, Johansson K-A, Mijnheer BJ, VandenBogaert W, vanTienhoven G: Quality assurance in conservative treatment of early breast cancer. Radiother Oncol 22: 323-326, 1991Google Scholar
  4. 4.
    Bornstein BA, Cheng CW, Rhodes LM, Rashid H, Stomper PC, Siddon RL: Can simulation measurements be used to predict the irradiated lung volume in the tangential fields in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 18: 181-187, 1990Google Scholar
  5. 5.
    Lind PARM: Short-term pulmonary side-effects following radiation therapy in breast cancer. Doctoral thesis, Karolinska Institute, Stockholm, Sweden, 1999Google Scholar
  6. 6.
    Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [see comments]. Int J Radiat Oncol Biol Phys 45(2): 323-329, 1999Google Scholar
  7. 7.
    Graham MV, Purdy JA, Emami B, Matthews JW, Harms WB: Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 33: 993-1000, 1995Google Scholar
  8. 8.
    Lind PARM, Rosfors S, Wennberg B, Glas U, Bevegård S, Fornander T: Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional tretament planning. Radiother Oncol 49: 245-254, 1998Google Scholar
  9. 9.
    Marks LB, Halperin EC, Prosnitz LR, Ross M, Vredenburgh JJ, Rosner GL: Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer with &10 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 23: 1021-1026, 1992Google Scholar
  10. 10.
    Gage I, Bond S, Davidson NE, Clarke BV, McIntyre J, Fetting J: Minimal acute toxicity associated with locoregional radiation therapy following 2 high-dose chemotherapy regimens (HDC) supported with autologous marrow/stem-cell transplantation in high risk breast cancer patients. Proc Am Soc Clin Oncol 17: 121a (abstr. 463), 1998Google Scholar
  11. 11.
    Taghian AG, Assaad S, Kuter I, Younger J, Schoenthaler R, Czito B: Increased risk of radiation pneumonitis in breast cancer patients treated by concomitant taxol and radiation therapy. Int J Radiat Oncol Biol Phys 45(3, suppl): 316a (abstr. 2074), 1999Google Scholar
  12. 12.
    Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J: Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 88: 918-922, 1996Google Scholar
  13. 13.
    Bjermer L, Franzén L, Littbrand B, Nilsson K, Ångström T, Henriksson R: Effects of smoking and irradiated volume of inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. Cancer Res 50: 2027-2030, 1990Google Scholar
  14. 14.
    Theuws JC, Kwa SL, Wagenaar AC, Boersma LJ, Damen EM, Muller SH: Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 48(1): 33-43, 1998Google Scholar
  15. 15.
    Cancer Therapy Evaluation Program, Common Toxicity Criteria, Version 2.0 DCTD, NCI, DHHS, March 1998Google Scholar
  16. 16.
    Siegel S, Catellan Jr N: Nonparametric Statistics for Behavioral Sciences. 2nd ed. McGraw-Hill, New York, 1988Google Scholar
  17. 17.
    Bentel GC, Marks LB, Hardenbergh PH, Prosnitz LR: Routine CT-based treatment planning for patients with breast cancer. Int J Radiat Oncol Biol Phys 42: 127a (abstr. 5), 1998Google Scholar
  18. 18.
    Gagliardi G: Modeling heart and lung complication data in radiation therapy of the breast. PhD thesis, Stockholm University, Stockholm, Sweden, 1998Google Scholar
  19. 19.
    Gyenes G: Cardiac side-effects of adjuvant radiotherapy for early breast cancer. Doctoral thesis, Karolinska Institute, Stockholm, Sweden, 1997Google Scholar
  20. 20.
    Theuws JC, Seppenwoolde Y, Kwa SL, Boersma LJ, Damen EM, Baas P: Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys 47(5): 1201-1208, 2000Google Scholar
  21. 21.
    Theuws JC, Muller SH, Seppenwoolde Y, Kwa SL, Boersma LJ, Hart GA: Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: a follow-up study. J Clin Oncol 17(10): 3091-3100, 1999Google Scholar
  22. 22.
    Kaufman J, Gunn W, Hartz AJ, Fischer M, Hoffman RG, Schlueter DP: The pathophysiologic and roentgenologic effects of chest irradiation in breast carcinoma. Int J Radiat Oncol Biol Phys 12: 887-893, 1986Google Scholar
  23. 23.
    Lind PARM, Bylund H, Wennberg B, Svensson C, Svane G: Abnormalities on chest radiographs following radiation therapy for breast cancer. European Radiol 10: 484-489, 2000Google Scholar
  24. 24.
    Lind PA, Svane G, Gagliardi G, Svensson C: Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer [see comments]. Int J Radiat Oncol Biol Phys 43(3): 489-496, 1999Google Scholar
  25. 25.
    Byhardt RW, Martin L, Pajak TF, Shin KH, Emami B, Cox JD: The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Radiat Oncol Biol Phys 27(3): 537-544, 1993Google Scholar
  26. 26.
    Kwa SL, Lebesque JV, Theuws JC, Marks LB, Munley MT, Bentel G: Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42(1): 1-9, 1998Google Scholar
  27. 27.
    Liao ZX, Travis EL, Tucker SL: Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung [see comments]. Int J Radiat Oncol Biol Phys 32(5): 1359-1370, 1995Google Scholar
  28. 28.
    Lyman JT, Wolbarst AB: Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13: 103-109, 1987Google Scholar
  29. 29.
    Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R: Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21(1): 137-146, 1991Google Scholar
  30. 30.
    Jackson A, Kutcher GJ, Yorke ED: Probability of radiationinduced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 20: 613-625, 1993Google Scholar
  31. 31.
    Yorke ED, Kutcher GJ, Jackson A, Ling CC: Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 26(3): 226-237, 1993Google Scholar
  32. 32.
    Niemierko A, Goitein M: Modeling of normal tissue response to radiation: the critical volume model [see comments]. Int J Radiat Oncol Biol Phys 25(1): 135-145, 1993Google Scholar
  33. 33.
    Kwa S, Theuws J, Wagenaar A, Damen E, Boersma L, Baas P: Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48: 61-69, 1998Google Scholar
  34. 34.
    Marks LB, Hebert ME, Bentel G, Spencer DP, Sherouse GW, Prosnitz LR: To treat or not to treat the internal mammary nodes: a possible compromise. Int J Radiat Oncol Biol Phys 29(4): 903-909, 1994Google Scholar
  35. 35.
    Freedman GM, Fowble BL, Nicolaou N, Sigurdson ER, Torosian MH, Boraas MC: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? [see comments]. Int J Radiat Oncol Biol Phys 46(4): 805-814, 2000Google Scholar
  36. 36.
    Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E: Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 47(4): 883-894, 2000Google Scholar
  37. 37.
    Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337: 949-955, 1997Google Scholar
  38. 38.
    Overgaard M, Jensen M-B, Overgaard J, Hansen PS, Rose C, Andersson M: Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Group DBCG 82c randomised trial. Lancet 353(9165): 1641-1648, 1999Google Scholar
  39. 39.
    Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE: Adjuvant radiotherapy and chemotherapy in nodepositive premenopausal women with breast cancer. N Engl J Med 337(14): 956-962, 1997Google Scholar
  40. 40.
    Diab SG, Hilsenbeck SG, deMoor C, Clark GM, Osborne CK, Ravdin PM: Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. J Clin Oncol 16: 1655-1660, 1998Google Scholar
  41. 41.
    Bartelink H, Borger J, Fourquet A, Gerard JP, Horiot JC, Kurtz J: Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer. EORTC-protocol 22922-10925, 1996Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Pehr A.R.M Lind
    • 1
    • 2
  • Berit Wennberg
    • 3
  • Giovanna Gagliardi
    • 4
  • Tommy Fornander
    • 5
  1. 1.Department of RadiotherapyHuddinge University HospitalSweden
  2. 2.Department of Radiation OncologyDuke University Medical CenterUSA
  3. 3.Department of Medical PhysicsHuddinge University HospitalSweden
  4. 4.Department of Hospital PhysicsKarolinska HospitalStockholmSweden
  5. 5.Department of RadiotherapyHuddinge University HospitalSweden

Personalised recommendations